161 results
DEFA14A
AGIO
Agios Pharmaceuticals Inc
26 Apr 24
Additional proxy soliciting materials
4:05pm
of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. Note: The proxies
8-K
EX-99.2
xq4fokw
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
8-K
EX-99.1
08xd5hnnfylir3qi7jw7
3 Aug 23
Agios Reports Business Highlights and Second Quarter 2023 Financial Results
6:38am
8-K
r85ka
14 Jun 23
Departure of Directors or Certain Officers
4:05pm
S-8
EX-23.2
8ft20tff
13 Jun 23
Registration of securities for employees
4:13pm
S-8
EX-99.1
tfu27d74t g4os6f21
13 Jun 23
Registration of securities for employees
4:13pm
S-8
nx49hb4es8f 4gwnrd
13 Jun 23
Registration of securities for employees
4:13pm
8-K
61dxcg7 cy5
25 May 23
Departure of Directors or Certain Officers
4:02pm
DEFA14A
zsqv3lm
26 Apr 23
Additional proxy soliciting materials
4:05pm
S-8
yycyqwt3s4vu4zp
26 Sep 22
Registration of securities for employees
5:19pm
S-8
EX-23.2
m7gjvsulnhzm1g5i 9j
26 Sep 22
Registration of securities for employees
5:19pm